Becton, Dickinson and Company BDX
Set alert
At close · Oct 30
After hours · Oct 30, 4:05 PM ET
- YTD
- +29.70%
- 1 year
- +40.32%
- Open
- 199.77
- Prev close
- 198.34
- Mkt cap
- 53.90B
- Vol
- 2.92M
- Avg vol
- 1.73M
- EPS
- 4.30
- P/E
- 46.02
- Div yield
- 2.12%
More statistics
- Low
- 197.06
- High
- 199.94
- Forward P/E
- 14.87
- Beta
- 0.28
- Short ratio
- 4.88
- Inst. own
- 99.68%
- Dividend
- 4.20
- Ex-div date
- Sep 8, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 186.39
- 200-d avg
- 165.81
- 1y target
- 195.57
5Y chart
Events in this range
- Dec 9, 2021Dividend: 0.87
- Mar 9, 2022Dividend: 0.87
- Apr 1, 2022Split: 1025 for 1000
- Jun 8, 2022Dividend: 0.87
- Sep 8, 2022Dividend: 0.87
- Dec 8, 2022Dividend: 0.91
- Dec 30, 2022Dividend: 0.91
- Mar 9, 2023Dividend: 0.91
- Jun 8, 2023Dividend: 0.91
- Sep 7, 2023Dividend: 0.91
- Dec 7, 2023Dividend: 0.95
- Mar 7, 2024Dividend: 0.95
- Jun 7, 2024Dividend: 0.95
- Jun 10, 2024Dividend: 0.95
- Sep 9, 2024Dividend: 0.95
- Dec 9, 2024Dividend: 1.04
- Mar 10, 2025Dividend: 1.04
- Jun 9, 2025Dividend: 1.04
- Aug 7, 2025Earnings: 3.68; estimate 3.4; surprise 8.24%
- Sep 8, 2025Dividend: 1.04
- Nov 6, 2025Earnings: 3.96; estimate 3.92; surprise 1.02%
- Dec 8, 2025Dividend: 1.05
- Feb 9, 2026Earnings: 2.91; estimate 2.21; surprise 31.67%
- Mar 10, 2026Dividend: 1.05
- May 7, 2026Earnings: 2.9; estimate 2.78; surprise 4.32%
- Jun 9, 2026Dividend: 1.05
- Aug 6, 2026Earnings: 3.23; estimate 3.14; surprise 2.87%
- Aug 7, 2026Rating: Piper Sandler · Neutral → Neutral
- Aug 7, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Aug 7, 2026Rating: Citigroup · Buy → Buy
- Aug 13, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Aug 31, 2026Rating: B of A Securities · Neutral → Neutral
- Sep 9, 2026Dividend: 1.05
- Oct 7, 2026Rating: Barclays · — → Underweight
- Nov 5, 2026Earnings: —; estimate 4.07; surprise —%
Signals (111)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| RSI: Overbought | Feb 16, 2026 | 8 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| RSI: Oversold | Jun 9, 2025 | 1 year ago |
| RSI: Oversold | Apr 28, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| SMA: Bullish | Jan 6, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 6, 2025 | 1 year ago |
| SMA: Bullish | Dec 23, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 4, 2024 | 1 year ago |
| SMA: Bearish | Oct 28, 2024 | 2 years ago |
| SMA: Bearish | Oct 28, 2024 | 2 years ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| SMA: Bearish | Oct 7, 2024 | 2 years ago |
| SMA: Bullish | Sep 23, 2024 | 2 years ago |
| SMA: Bullish | Sep 23, 2024 | 2 years ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| SMA: Bullish | Aug 26, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| SMA: Bullish | Jul 22, 2024 | 2 years ago |
| SMA: Bullish | Jul 22, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 22, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 24, 2024 | 2 years ago |
| SMA: Bearish | Jun 24, 2024 | 2 years ago |
| SMA: Bullish | Jun 17, 2024 | 2 years ago |
| SMA: Bullish | Jun 17, 2024 | 2 years ago |
| SMA: Bearish | Jun 10, 2024 | 2 years ago |
| SMA: Bearish | Jun 10, 2024 | 2 years ago |
| SMA: Bullish | Jun 3, 2024 | 2 years ago |
| SMA: Bullish | Jun 3, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 3, 2024 | 2 years ago |
| MACD: Sell Signal | May 20, 2024 | 2 years ago |
| MACD: Buy Signal | May 13, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| SMA: Bullish | Mar 25, 2024 | 2 years ago |
| SMA: Bullish | Mar 18, 2024 | 2 years ago |
| SMA: Bearish | Mar 11, 2024 | 2 years ago |
| SMA: Bullish | Mar 4, 2024 | 2 years ago |
| SMA: Bearish | Feb 26, 2024 | 2 years ago |
| SMA: Bullish | Feb 5, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 5, 2024 | 2 years ago |
| SMA: Bearish | Jan 8, 2024 | 2 years ago |
| SMA: Bullish | Dec 18, 2023 | 2 years ago |
| SMA: Bearish | Oct 9, 2023 | 3 years ago |
| SMA: Bullish | Oct 2, 2023 | 3 years ago |
| SMA: Bearish | Sep 25, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 11, 2023 | 3 years ago |
| SMA: Bearish | Sep 4, 2023 | 3 years ago |
| SMA: Bullish | Jun 12, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 12, 2023 | 3 years ago |
| SMA: Bullish | May 29, 2023 | 3 years ago |
| SMA: Bearish | May 22, 2023 | 3 years ago |
| SMA: Bearish | May 22, 2023 | 3 years ago |
| MACD: Sell Signal | May 22, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 3, 2023 | 3 years ago |
| SMA: Bullish | Mar 27, 2023 | 3 years ago |
| SMA: Bullish | Mar 27, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 20, 2023 | 3 years ago |
| SMA: Bearish | Feb 13, 2023 | 3 years ago |
| SMA: Bearish | Jan 30, 2023 | 3 years ago |
| SMA: Bullish | Nov 28, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 28, 2022 | 3 years ago |
| SMA: Bullish | Nov 21, 2022 | 3 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 19, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 15, 2022 | 4 years ago |
| SMA: Bullish | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bearish | Jul 4, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bearish | May 30, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bullish | Mar 21, 2022 | 4 years ago |
| SMA: Bearish | Mar 7, 2022 | 4 years ago |
Key statistics
- Market cap
- 53.88B
- Enterprise value
- 70.12B
- Trailing P/E
- 46.00
- Forward P/E
- 14.87
- PEG ratio
- 1.11
- Price / sales
- 2.40
- Price / book
- 2.21
- EPS (TTM)
- 4.30
- Beta
- 0.28
- Dividend yield
- 2.12%
- Payout ratio
- 72.49%
- Profit margin
- 4.19%
- Revenue (TTM)
- 22.48B
- Revenue growth
- 5.40%
- Free cash flow
- 4.48B
- Total cash
- 709.00M
- Total debt
- 16.81B
- Return on equity
- 6.61%
- Shares outstanding
- 272.39M
- Short % of float
- 3.73%
- 50-day average
- 186.39
- 200-day average
- 165.81
Analyst view
Consensus: buy
- Target (low)
- 165.00
- Target (mean)
- 195.57
- Target (high)
- 225.00
- Strong buy1
- Buy7
- Hold7
- Sell0
- Strong sell1
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 4.07.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 4.07 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 3.14 | 3.23 | +0.09 | +2.87% |
| May 7, 2026 | Mar 31, 2026 | 2.78 | 2.90 | +0.12 | +4.32% |
| Feb 9, 2026 | Dec 31, 2025 | 2.21 | 2.91 | +0.70 | +31.67% |
| Nov 6, 2025 | Sep 30, 2025 | 3.92 | 3.96 | +0.04 | +1.02% |
| Aug 7, 2025 | Jun 30, 2025 | 3.40 | 3.68 | +0.28 | +8.24% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 7, 2026 | Barclays | init | — | Underweight |
| Aug 31, 2026 | B of A Securities | main | Neutral | Neutral |
| Aug 13, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
| Aug 7, 2026 | Citigroup | main | Buy | Buy |
| Aug 7, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
| Aug 7, 2026 | Piper Sandler | main | Neutral | Neutral |
About Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- bd.com
News
- Becton Dickinson (BDX) Earnings Expected to Grow: Should You Buy?
- American Century Equity Income Fund Q3 2026 Portfolio Activity
- Best Dividend Aristocrats For November 2026
- BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options
- Citizens Financial Group Inc. RI Purchases 4,390 Shares of Becton, Dickinson and Company $BDX
- First Eagle Global Fund Q3 202 Portfolio Update
- First Eagle U.S. Value Fund Q3 2026 Portfolio Review
- Best Dividend Kings: October 2026
- The Dividend Aristocrats Ranked By Quality Scores (October 2026)
- BDX Stock Gains 25.5% in Six Months: What's Behind the Rally?
Your note
Sign in to keep a note on BDX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DELOREFICE CHRISTOPHER | Chief Financial Officer | Stock Award(Grant) | Nov 25, 2025 | 22,982 |
| FELD MICHAEL | Officer | Sale | Oct 25, 2026 | 19,568 |
| FRASER CLAIRE | Director | Sale | Sep 9, 2025 | 22,226 |
| GOETTE ROLAND | Officer | Sale | Aug 10, 2026 | 16,635 |
| JONES CHRISTOPHER IAN MONTAGUE | Director | Stock Award(Grant) | Jan 26, 2026 | 24,304 |
| MUHSIN BILAL | Officer | Stock Award(Grant) | Jun 30, 2026 | 41,359 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.93% | 24,592,166 | 4.86B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.53% | 17,987,834 | 3.56B | Jun 29, 2026 |
| State Street Corporation | 5.44% | 15,000,064 | 2.97B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.43% | 14,974,136 | 2.96B | Jun 29, 2026 |
| First Eagle Investment Management, LLC | 5.01% | 13,815,335 | 2.73B | Jun 29, 2026 |
| Invesco Ltd. | 3.23% | 8,898,488 | 1.76B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| First Eagle Funds-First Eagle Global Fund | 3.32% | 9,151,995 | 1.81B | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 8,747,261 | 1.73B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 7,136,026 | 1.41B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.17% | 5,970,167 | 1.18B | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.32% | 3,629,584 | 717.97M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.30% | 3,576,755 | 707.52M | Aug 30, 2026 |